{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:31:48Z","timestamp":1791570708515,"version":"4.3.4"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The rise in xylazine-adulterated heroin and fentanyl poses novel challenges to hand surgeons and a rising epidemic of necrotic upper-extremity wounds. While prior case studies have focused on particularly severe and complex xylazine-associated necrotic (XAN) wounds, the aim of this consecutive case series was to characterize the variability of presentations (ranging from mild to severe) at a single institution at the epicenter of the xylazine epidemic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Patients presenting to a tertiary referral center for XAN upper-extremity wounds were retrospectively identified from emergency department visits and hospital admissions between January 2021 and December 2023. Patient characteristics, clinical findings, treatment, and hospitalization-related measures were recorded. Wounds were classified according to the depth, density, size, and presence of osteomyelitis. All of the variables were quantified using descriptive statistics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In total, 82 patients with 125 XAN wounds were included in the study. The mean age was 40.3 \u00b1 8.2 years, and 57% of the patients were men. Of the 125 wounds, 54% had associated osteomyelitis, 78% were confluent, and 47%involved more than two-thirds of the anatomic region. Surgery was recommended for 78% of the patients and was performed in 62%, with 13% undergoing amputation. Complications rates were high (77%) and included bacteremia (40%) and death (5%). Patients were hospitalized a mean of 4.1 times and were discharged against medical advice 2.8 times per year.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This study presents a broad perspective on demographic, social, and medical factors in patients with XAN wounds of the upper extremity. Given the complexity and burden of this public health crisis, early intervention is important to prevent complications and mitigate costs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>\n                      Therapeutic\n                      <jats:underline>Level IV<\/jats:underline>\n                      . See Instructions for Authors for a complete description of levels of evidence.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.2106\/jbjs.24.00534","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T14:02:24Z","timestamp":1734962544000},"page":"279-286","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Xylazine-Associated Necrotic Upper-Extremity Wounds"],"prefix":"10.2106","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1241-5815","authenticated-orcid":false,"given":"Sebastian D.","family":"Arango","sequence":"first","affiliation":[{"name":"Philadelphia Hand to Shoulder Center, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2880-0474","authenticated-orcid":false,"given":"Jason C.","family":"Flynn","sequence":"additional","affiliation":[{"name":"Thomas Jefferson University Hospital, Sidney Kimmel Medical College, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6962-5100","authenticated-orcid":false,"given":"Jacob H.","family":"Zeitlin","sequence":"additional","affiliation":[{"name":"Philadelphia Hand to Shoulder Center, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9773-3013","authenticated-orcid":false,"given":"Tristan B.","family":"Weir","sequence":"additional","affiliation":[{"name":"Philadelphia Hand to Shoulder Center, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6828-823X","authenticated-orcid":false,"given":"Andrew J.","family":"Miller","sequence":"additional","affiliation":[{"name":"Philadelphia Hand to Shoulder Center, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"bib2-20260615","year":"2022","journal-title":"Xylazine."},{"issue":"3","key":"bib3-20260615","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11524-011-9662-6","article-title":"The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico","volume":"89","author":"Reyes","year":"2012","journal-title":"J Urban Health."},{"issue":"37","key":"bib4-20260615","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.15585\/mmwr.mm7037a4","article-title":"Notes from the Field: Xylazine Detection and Involvement in Drug Overdose Deaths - United States, 2019","volume":"70","author":"Kariisa","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"bib5-20260615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2014.03.015","article-title":"Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: A comprehensive review of the literature","volume":"240","author":"Ruiz-Col\u00f3n","year":"2014","journal-title":"Forensic Sci Int."},{"key":"bib6-20260615","doi-asserted-by":"crossref","first-page":"109380","DOI":"10.1016\/j.drugalcdep.2022.109380","article-title":"Xylazine spreads across the US: A growing component of the increasingly synthetic and polysubstance overdose crisis","volume":"233","author":"Friedman","year":"2022","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"bib7-20260615","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.jaad.2023.04.009","article-title":"Skin ulcerations caused by xylazine: A lesser-known entity","volume":"89","author":"Bishnoi","year":"2023","journal-title":"J Am Acad Dermatol."},{"issue":"4","key":"bib8-20260615","first-page":"249","article-title":"Xylazine infusion in isoflurane-anesthetized and ventilated healthy horses: Effects on cardiovascular parameters and intestinal perfusion","volume":"81","author":"Hopster","year":"2017","journal-title":"Can J Vet Res."},{"issue":"1","key":"bib9-20260615","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/PAF.0000000000000622","article-title":"Xylazine, a Veterinary Tranquilizer, Detected in 42 Accidental Fentanyl Intoxication Deaths","volume":"42","author":"Nunez","year":"2021","journal-title":"Am J Forensic Med Pathol."},{"issue":"7","key":"bib10-20260615","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.tiv.2014.06.013","article-title":"Toxic effects of xylazine on endothelial cells in combination with cocaine and 6-monoacetylmorphine","volume":"28","author":"Silva-Torres","year":"2014","journal-title":"Toxicol In Vitro."},{"issue":"8","key":"bib11-20260615","first-page":"e28160","article-title":"Xylazine-Induced Skin Ulcers in a Person Who Injects Drugs in Philadelphia, Pennsylvania, USA","volume":"14","author":"Malayala","year":"2022","journal-title":"Cureus."},{"issue":"24","key":"bib12-20260615","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1056\/NEJMicm2303601","article-title":"Xylazine-Associated Skin Injury","volume":"388","author":"O\u2019Neil","year":"2023","journal-title":"N Engl J Med."},{"key":"bib13-20260615","doi-asserted-by":"crossref","first-page":"100247","DOI":"10.1016\/j.dadr.2024.100247","article-title":"Xylazine awareness, desire, use and exposure: Preliminary findings from the Rhode Island community-based drug checking cohort study","volume":"11","author":"Park","year":"2024","journal-title":"Drug Alcohol Depend Rep."},{"key":"bib14-20260615","doi-asserted-by":"crossref","first-page":"100074","DOI":"10.1016\/j.dadr.2022.100074","article-title":"Perspectives of people in Philadelphia who use fentanyl\/heroin adulterated with the animal tranquilizer xylazine; Making a case for xylazine test strips","volume":"4","author":"Reed","year":"2022","journal-title":"Drug Alcohol Depend Rep."},{"key":"bib15-20260615","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jdcr.2023.04.010","article-title":"Xylazine-induced acute skin necrosis in two patients who inject fentanyl","volume":"36","author":"Rose","year":"2023","journal-title":"JAAD Case Rep."},{"issue":"5","key":"bib16-20260615","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jhsa.2023.04.001","article-title":"Necrotic Upper-Extremity Infections in People Who Inject Drugs: A Case Series","volume":"49","author":"Soderquist","year":"2024","journal-title":"J Hand Surg Am."},{"issue":"24","key":"bib17-20260615","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMp2303120","article-title":"Xylazine - Medical and Public Health Imperatives","volume":"388","author":"Gupta","year":"2023","journal-title":"N Engl J Med."},{"issue":"3","key":"bib18-20260615","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cveq.2010.08.002","article-title":"Treatment of visceral pain in horses","volume":"26","author":"Robertson","year":"2010","journal-title":"Vet Clin North Am Equine Pract."},{"issue":"3","key":"bib19-20260615","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.drugalcdep.2008.03.005","article-title":"GC-MS confirmation of xylazine (Rompun), a veterinary sedative, in exchanged needles","volume":"96","author":"Rodr\u00edguez","year":"2008","journal-title":"Drug Alcohol Depend."},{"issue":"11","key":"bib21-20260615","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.jhsa.2015.08.002","article-title":"Inadvertent Intra-Arterial Drug Injections in the Upper Extremity: Systematic Review","volume":"40","author":"Devulapalli","year":"2015","journal-title":"J Hand Surg Am."},{"issue":"2","key":"bib22-20260615","doi-asserted-by":"crossref","first-page":"e2116","DOI":"10.1097\/GOX.0000000000002116","article-title":"Intravenous Drug Use-Related Complications of the Hand and Upper Extremity","volume":"7","author":"Pong","year":"2019","journal-title":"Plast Reconstr Surg Glob Open."},{"issue":"1","key":"bib23-20260615","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.surge.2014.08.003","article-title":"A comparative analysis of the patient characteristics and cost of managing intravenous drug users (IVDU) with soft tissue abscesses with non-IVDU","volume":"14","author":"Chotai","year":"2016","journal-title":"Surgeon."},{"issue":"11","key":"bib24-20260615","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1007\/s11606-022-07618-x","article-title":"A Taxonomy of Hospital-Based Addiction Care Models: a Scoping Review and Key Informant Interviews","volume":"37","author":"Englander","year":"2022","journal-title":"J Gen Intern Med."},{"issue":"6","key":"bib25-20260615","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jamainternmed.2023.7282","article-title":"Caring for Hospitalized Adults With Opioid Use Disorder in the Era of Fentanyl: A Review","volume":"184","author":"Englander","year":"2024","journal-title":"JAMA Intern Med."},{"issue":"5","key":"bib26-20260615","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1176\/appi.ajp.20230918","article-title":"Harm Reduction for Opioid Use Disorder: Strategies and Outcome Metrics","volume":"181","author":"Ellis","year":"2024","journal-title":"Am J Psychiatry."},{"key":"bib27-20260615","doi-asserted-by":"crossref","first-page":"104206","DOI":"10.1016\/j.drugpo.2023.104206","article-title":"A survey of North American drug checking services operating in 2022","volume":"121","author":"Park","year":"2023","journal-title":"Int J Drug Policy."},{"key":"bib28-20260615","doi-asserted-by":"crossref","first-page":"100241","DOI":"10.1016\/j.dadr.2024.100241","article-title":"Pilot findings on the real-world performance of xylazine test strips for drug residue testing and the importance of secondary testing methods","volume":"11","author":"Thompson","year":"2024","journal-title":"Drug Alcohol Depend Rep."},{"key":"bib29-20260615","doi-asserted-by":"crossref","first-page":"103741","DOI":"10.1016\/j.drugpo.2022.103741","article-title":"Take-home drug checking as a novel harm reduction strategy in British Columbia, Canada","volume":"106","author":"Klaire","year":"2022","journal-title":"Int J Drug Policy."},{"issue":"2","key":"bib31-20260615","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.5435\/JAAOS-D-17-00716","article-title":"Necrotizing Infections of the Hand and Wrist: Diagnosis and Treatment Options","volume":"28","author":"Choueka","year":"2020","journal-title":"J Am Acad Orthop Surg."}],"container-title":["Journal of Bone and Joint Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.24.00534","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:41:13Z","timestamp":1787751673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2106\/JBJS.24.00534"}},"subtitle":["A Single Hospital System\u2019s Experience with 82 Patients and 125 Wounds"],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.24.00534","relation":{},"ISSN":["0021-9355","1535-1386"],"issn-type":[{"value":"0021-9355","type":"print"},{"value":"1535-1386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]}}}